Not Yet Recruiting NA INTERVENTIONAL 1-arm NCT06671340

Chronic Dorzagliatin on Insulin and Incretin Function in Intermediate Hyperglycemia and Type 2 Diabetes

Effects of Repeated Dose of Dorzagliatin on Insulin Secretion, Glucagon Release and Incretin Function in Intermediate Hyperglycemia and Type 2 Diabetes

Sponsor: Elaine Chow

Conditions Diabetes Mellitus Prediabetes / Type 2 Diabetes

Interventions Dorzagliatin

Updated 2 times since 2024 Last updated: Mar 1, 2025 Started: Apr 2, 2025 Primary completion: Dec 30, 2025 Completion: Jan 31, 2026

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Diabetes Mellitus and Prediabetes / Type 2 Diabetes and is currently actively recruiting participants. Elaine Chow leads this study, which shows 2 recorded versions since 2025 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

2 versions recorded

Apr 2025 — Present [monthly]

Not Yet Recruiting NA
Dec 2024 — Apr 2025 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Elaine Chow

Data source: Chinese University of Hong Kong

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Hong Kong, Hong Kong